A trithiol bifunctional chelate for 72,77As: A matched pair theranostic complex with high in vivo stability
Journal Article
·
· Nuclear Medicine and Biology
- Univ. of Missouri, Columbia, MO (United States). Dept. of Chemistry
- Univ. of Missouri, Columbia, MO (United States). Dept. of Chemistry; Brookhaven National Lab. (BNL), Upton, NY (United States). Medical Isotope Research and Production Program (MIRP). Collider-Accelerator Dept.
- Harry S. Truman Memorial Veterans' Hospital, Columbia, MO (United States). Research Service
- Univ. of Missouri, Columbia, MO (United States). Molecular Interaction Core
- Univ. of Missouri, Columbia, MO (United States). Research Reactor Center (MURR); Brookhaven National Lab. (BNL), Upton, NY (United States). Medical Isotope Research and Production Program (MIRP). Collider-Accelerator Dept.
- Univ. of Missouri, Columbia, MO (United States). Research Reactor Center (MURR)
- Univ. of Missouri, Columbia, MO (United States). Dept. of Chemistry. Research Reactor Center (MURR)
Trithiol chelates are suitable for labeling radioarsenic (72As: 2.49 MeV β+, 26 h; 77As: 0.683 MeV β-, 38.8 h) to form potential theranostic radiopharmaceuticals for PET imaging and therapy. In this paper, to investigate the in vivo stability of trithiol chelates complexed with no carrier added (nca) radioarsenic, a bifunctional trithiol chelate was developed, and conjugated to bombesin(7–14)NH2 as a model peptide. A trithiol-BBN(7–14)NH2 bioconjugate and its arsenic complex were synthesized and characterized. The trithiol-BBN(7–14)NH2 conjugate was radiolabeled with 77As, its in vitro stability assessed, and biodistribution studies were performed in CF-1 normal mice of free [77As]arsenate and 77As-trithiol- BBN(7–14)NH2. The trithiol-BBN(7–14)NH2 conjugate, its precursors and its As-trithiol-BBN(7–14)NH2 complex were fully characterized. Radiolabeling studies with nca 77As resulted in over 90% radiochemical yield of 77As-trithiol-BBN, which was stable for over 48 h. Biodistribution studies were performed with both free [77As]arsenate and Sep-Pak® purified 77As-trithiol-BBN(7–14)NH2. Compared to the fast renal clearance of free [77As]arsenate, 77As-trithiol-BBN(7–14)NH2 demonstrated increased retention with clearance mainly through the hepatobiliary system, consistent with the lipophilicity of the 77As-trithiol-BBN(714)NH2 complex. Finally, the combined in vitro stability of 77As-trithiol-BBN(7–14)NH2 and the biodistribution results demonstrate its high in vivo stability, making the trithiol a promising platform for developing radioarsenic-based theranostic radiopharmaceuticals.
- Research Organization:
- Brookhaven National Lab. (BNL), Upton, NY (United States); Harry S. Truman Memorial Veterans' Hospital, Columbia, MO (United States); Univ. of Missouri, Columbia, MO (United States)
- Sponsoring Organization:
- Dept. of Veterans Affairs (VA) (United States); National Inst. of Health (NIH) (United States); USDOE; USDOE Office of Science (SC), Nuclear Physics (NP) (SC-26)
- Grant/Contract Number:
- SC0003851; SC0010283; SC0012704
- OSTI ID:
- 1464108
- Alternate ID(s):
- OSTI ID: 1544917
- Report Number(s):
- BNL--207952-2018-JAAM
- Journal Information:
- Nuclear Medicine and Biology, Journal Name: Nuclear Medicine and Biology Vol. 61; ISSN 0969-8051
- Publisher:
- ElsevierCopyright Statement
- Country of Publication:
- United States
- Language:
- English
Similar Records
Development and biodistribution studies of 77As-labeled trithiol RM2 bioconjugates for prostate cancer: Comparison of [77As]As-trithiol-Ser-Ser-RM2 vs. [77As]As-trithiol-Glu-Ser-RM2
Trithiol ligand provides tumor-targeting 191Pt-complexes with high molar activity and promising in vivo properties
High Yield Production and Radiochemical Isolation of Isotopically Pure Arsenic-72 and Novel Radioarsenic Labeling Strategies for the Development of Theranostic Radiopharmaceuticals
Journal Article
·
Tue Mar 15 20:00:00 EDT 2022
· Nuclear Medicine and Biology
·
OSTI ID:1854922
Trithiol ligand provides tumor-targeting 191Pt-complexes with high molar activity and promising in vivo properties
Journal Article
·
Mon Jun 09 20:00:00 EDT 2025
· Nuclear Medicine and Biology
·
OSTI ID:3001505
High Yield Production and Radiochemical Isolation of Isotopically Pure Arsenic-72 and Novel Radioarsenic Labeling Strategies for the Development of Theranostic Radiopharmaceuticals
Journal Article
·
Mon Dec 07 19:00:00 EST 2015
· Bioconjugate Chemistry
·
OSTI ID:1467565